Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2022 Aug 4

PMID 35926153

Authors

Beverly Moy

R Bryan Rumble

Lisa A Carey

Affiliations

Soon will be listed here.

Abstract

Citing Articles

Bar Y, Fell G, Dedeoglu A, Moffett N, Vidula N, Spring L NPJ Breast Cancer. 2025; 11(1):27.

PMID: 40069204 PMC: 11897376. DOI: 10.1038/s41523-025-00741-y.

Bardia A, Jhaveri K, Im S, Pernas S, De Laurentiis M, Wang S J Clin Oncol. 2024; 43(3):285-296.

PMID: 39265124 PMC: 11771365. DOI: 10.1200/JCO.24.00920.

Levine M, Kemppainen J, Rosenberg M, Pettengell C, Bogach J, Whelan T Learn Health Syst. 2024; 8(3):e10409.

PMID: 39036532 PMC: 11257056. DOI: 10.1002/lrh2.10409.

Neubauer Z, Hasan S, Press R, Chhabra A, Fox J, Bakst R Cancer Med. 2024; 13(2):e6979.

PMID: 38379326 PMC: 10839127. DOI: 10.1002/cam4.6979.

Al Sukhun S, Koczwara B, Temin S, Arun B JCO Glob Oncol. 2024; 10:e2300411.

PMID: 38206289 PMC: 10793985. DOI: 10.1200/GO.23.00411.